US drugmaker Pfizer has agreed to pay $2.3bn (£1.4bn) in the largest healthcare fraud settlement in the history of the Department of Justice.US drugmaker Pfizer had already alerted investors it was taking a $2.3 billion charge back in January - the same day it announced the $68 billion Wyeth purchase - and said Wednesday it would take another $33 million in charges to settle several state civil allegations.
US drugmaker Pfizer has agreed to pay $2.3bn (£1.4bn) in the largest healthcare fraud settlement in the history of the Department of Justice.US drugmaker Pfizer had already alerted investors it was taking a $2.3 billion charge back in January - the same day it announced the $68 billion Wyeth purchase - and said Wednesday it would take another $33 million in charges to settle several state civil allegations.
With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 26% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>
Zacks Top Ten Stocks for 2010 are now available! Last year's buy-and-hold picks generated a +29.6% return! This is one of our least expensive and easiest products to use, and also one of the most profitable! Be one of the first to get this year's picks. Learn more about Zacks Top Ten >>
Rated #1 best-performing stock newsletter over the past 10 years by independent Hulbert Financial Digest. Zacks Elite gives you full access to the power of the Zacks Rank, plus the private, hand picked Focus List, Timely Buys and Growth & Income Portfolios. Start a Free Trial Today >>
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment